MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Identification of xylopropamine as a potential dopamine D2 receptor agonist through computational drug discovery pipeline

    B. Ugbedeojo, P. Adoyi, A. Abah, O. Onimisi, S. Musa, A. Omoniyi (Zaria, Nigeria)

    Objective: This study aims to identify novel dopamine D2 receptor agonists through the computational drug discovery pipeline. Background: Parkinson's disease (PD) is a neurodegenerative disorder…
  • 2023 International Congress

    Accelerated longitudinal brain atrophy in the ‘diffuse malignant’ Parkinson’s disease subtype

    SM. Fereshtehnejad, R. Moqadam, R. Postuma, M. Dadar, Y. Zeighami (Ottawa, Canada)

    Objective: To investigate differential pattern of brain atrophy between Parkinson’s disease (PD) clinical subtypes using longitudinally acquired brain magnetic resonance imaging (MRIs). Background: Parkinson’s disease…
  • 2023 International Congress

    At-home adaptive deep brain stimulation improves motor fluctuations and quality of life in patients with Parkinson’s disease: a single-blind randomized study

    C. Oehrn, S. Cernera, L. Hammer, M. Shcherbakova, J. Yao, A. Hahn, C. Smyth, S. Little, P. Starr (San Francisco, USA)

    Objective: We evaluated the effect of at-home adaptive deep brain stimulation (aDBS) based on personalized neural biomarkers on motor symptoms and quality of life (QoL)…
  • 2023 International Congress

    VPS11 associated movement disorder in a pediatric case

    E. Serdaroglu, A. Serdaroglu (Ankara, Turkey)

    Objective: Disorders of intracellular trafficking may present with different neurological features such as pediatric movement disorders. Background: A 15-year-old boy presented with a three-year history…
  • 2023 International Congress

    Pain and moods disorders as determinants of quality of life in Parkinson

    D. Ortiz-Zacarias, I. Estrada-Bellmann, R. Estrella-Silva, J. Trejo-Ayala (Monterrey, Mexico)

    Objective: Correlation of non-motor symptoms such as pain, anxiety, and depression in the quality of life and severity of the disease in patients living with…
  • 2023 International Congress

    Movement disorders in children with progressive myoclonic epilepsies

    M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, I. Ben Youssef-Turki (Tunis, Tunisia)

    Objective: To analyze the clinical aspects, radiological features and evolution of myoclonus and other movement disorders (MD) in children with progressive myoclonic epilepsies (PMEs). Background:…
  • 2023 International Congress

    Factors influencing voice function after deep brain stimulation in Parkinson’s disease

    H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

    Objective: To assess the effect of Deep Brain Stimulation (DBS) on self-perceived changes of voice function in Parkinson’s disease (PD). Background: To date, the effect…
  • 2023 International Congress

    Association between type 2 diabetes mellitus with parkinson’s disease and the increase of the severity of depression and anxiety in a mexican population

    AA. Herrera Ruiz, DR. Aguila Godinez, AJ. Hernández-Medrano, MA. Ruiz Mafud, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To compare the severity of depression and anxiety in PwP between those with T2D and those without T2D. Background: Parkinson's disease (PD) is the…
  • 2023 International Congress

    Nonketotic hyperglycemia-induced hemichorea/hemiballism in El Salvador: A case Series

    R. Lopez-Castellanos, R. Lopez-Contreras (Atlanta, USA)

    Objective: We conducted a retrospective study to investigate the clinical characteristics of patients with nonketotic hyperglycemia-induced hemichorea/hemiballism referred to a movement disorder clinic in El…
  • 2023 International Congress

    Words Spoken Daily: A Novel Measure of Cognition

    S. Lettenberger, M. Zafar, J. Soto, Y. Zhang, G. Zhu, A. Masino, G. Nkrumah, E. Waddell, K. Spear, A. Arky, R. Toor, E. Hartman, J. Epifano, R. Christie, Z. Duan, R. Dorsey (Rochester, USA)

    Objective: To assess the average number of words spoken per day by individuals with Parkinson’s disease (PD), mild cognitive impairment (MCI), and control participants. Background:…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley